Evidence indicates that TAB are able to negatively modulate the tumor-immune microenvironment mainly by upregulating the expression of transforming growth factor beta 1 (TGF-β1) and high mobility group box 1 (HMGB1) proteins in tumor cells [6]. This evidence concerns the gene HMGB1 and neoplasm.